124P Surufatinib plus toripalimab combined with etoposide (E) and cisplatin (P) in patients (pts) with advanced naive small cell lung cancer (SCLC): Updated results of a phase Ib/II trial
W. Fang, Y. Yang, Y. Huang, Y. Zhao, Y. Zhang, T. Zhou, G. Chen, S. Zhao, Y. Ma, S. Hong, H. Zhao, L. Zhang
{"title":"124P Surufatinib plus toripalimab combined with etoposide (E) and cisplatin (P) in patients (pts) with advanced naive small cell lung cancer (SCLC): Updated results of a phase Ib/II trial","authors":"W. Fang, Y. Yang, Y. Huang, Y. Zhao, Y. Zhang, T. Zhou, G. Chen, S. Zhao, Y. Ma, S. Hong, H. Zhao, L. Zhang","doi":"10.1016/j.iotech.2023.100596","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":192507,"journal":{"name":"Immuno-Oncology and Technology","volume":"21 38‐39","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Immuno-Oncology and Technology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.iotech.2023.100596","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
